Literature DB >> 23371493

Abstinence from repeated amphetamine treatment induces depressive-like behaviors and oxidative damage in rat brain.

Yi Che1, Yong-Hua Cui, Hua Tan, Ana C Andreazza, L Trevor Young, Jun-Feng Wang.   

Abstract

RATIONALE: Amphetamine has a significant potential for abuse and addiction. Among prolonged abusers, amphetamine withdrawal-induced depressive symptoms are common; however, their pathophysiological mechanism is not fully understood. Previously, we found that repeated treatment with amphetamine for 2 weeks induced oxidative stress in rat brain.
OBJECTIVES: The purpose of the current study is to analyze whether abstinence from repeated amphetamine treatment in rats induces depressive-like behaviors and if oxidative damage in the brain continues during abstinence.
METHODS: Rats were given repeated treatment with amphetamine once daily at 1, 2, or 4 mg/kg for 14 days. From 10 to 14 days after final amphetamine treatment, behavioral changes were monitored using open field test, novel object recognition test, and forced swim test. Oxidative damage in the medial frontal cortex and hippocampus was analyzed by immunohistochemistry.
RESULTS: We found that drug abstinence after repeated amphetamine stimulation decreased locomotor activity and exploratory behavior in the open field test, increased immobility in the forced swim test, and had no significant effect on the recognition index in the novel object recognition test. We also found that amphetamine abstinence increased levels of 4-hydroxynonenal-protein adducts and 8-hydroxyguanosine in rat medial frontal cortex and in CA3 and dentate gyrus regions of the hippocampus.
CONCLUSIONS: These results suggest that amphetamine abstinence displays depressive-like behaviors in rats and induces oxidative damage to lipids and RNA in rat brain. Our findings indicate that the process of oxidative stress may play a role in pathophysiological changes during drug abstinence from repeated amphetamine stimulation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23371493     DOI: 10.1007/s00213-013-2993-0

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  32 in total

1.  Mood stabilizer lithium inhibits amphetamine-increased 4-hydroxynonenal-protein adducts in rat frontal cortex.

Authors:  Hua Tan; L Trevor Young; Li Shao; Yi Che; William G Honer; Jun-Feng Wang
Journal:  Int J Neuropsychopharmacol       Date:  2011-09-23       Impact factor: 5.176

Review 2.  Hypothetical role of RNA damage avoidance in preventing human disease.

Authors:  Damien Brégeon; Alain Sarasin
Journal:  Mutat Res       Date:  2005-09-04       Impact factor: 2.433

Review 3.  Mitochondria and reactive oxygen species. Which role in physiology and pathology?

Authors:  Giorgio Lenaz
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

4.  Effects of lithium and valproate on amphetamine-induced oxidative stress generation in an animal model of mania.

Authors:  Benicio N Frey; Samira S Valvassori; Gislaine Z Réus; Márcio R Martins; Fabrícia C Petronilho; Katrine Bardini; Felipe Dal-Pizzol; Flávio Kapczinski; João Quevedo
Journal:  J Psychiatry Neurosci       Date:  2006-09       Impact factor: 6.186

Review 5.  RNA oxidation in Alzheimer disease and related neurodegenerative disorders.

Authors:  Akihiko Nunomura; Tim Hofer; Paula I Moreira; Rudy J Castellani; Mark A Smith; George Perry
Journal:  Acta Neuropathol       Date:  2009-03-07       Impact factor: 17.088

6.  Changes in monoamine oxidase activity in mouse brain associated with d-methamphetamine dependence and withdrawal.

Authors:  T Egashira; Y Yamanaka
Journal:  Biochem Pharmacol       Date:  1993-08-17       Impact factor: 5.858

Review 7.  Treatment for amphetamine withdrawal.

Authors:  Steven J Shoptaw; Uyen Kao; Keith Heinzerling; Walter Ling
Journal:  Cochrane Database Syst Rev       Date:  2009-04-15

8.  Effects of lithium and valproate on serum and hippocampal neurotrophin-3 levels in an animal model of mania.

Authors:  Julio C Walz; Benício N Frey; Ana C Andreazza; Keila M Ceresér; Alice A Cacilhas; Samira S Valvassori; João Quevedo; Flávio Kapczinski
Journal:  J Psychiatr Res       Date:  2007-05-21       Impact factor: 4.791

Review 9.  Monoamine oxidase inactivation: from pathophysiology to therapeutics.

Authors:  Marco Bortolato; Kevin Chen; Jean C Shih
Journal:  Adv Drug Deliv Rev       Date:  2008-07-04       Impact factor: 15.470

Review 10.  A closer look at amphetamine-induced reverse transport and trafficking of the dopamine and norepinephrine transporters.

Authors:  S D Robertson; H J G Matthies; A Galli
Journal:  Mol Neurobiol       Date:  2009-02-06       Impact factor: 5.590

View more
  8 in total

1.  Diazepam reverses increased anxiety-like behavior, social behavior deficit, and dopamine dysregulation following withdrawal from acute amphetamine.

Authors:  Millie Rincón-Cortés; Kimberly G Gagnon; Hannah K Dollish; Anthony A Grace
Journal:  Neuropsychopharmacology       Date:  2018-06-18       Impact factor: 7.853

2.  Timing of amphetamine exposure in relation to puberty onset determines its effects on anhedonia, exploratory behavior, and dopamine D1 receptor expression in young adulthood.

Authors:  Shuo Kang; Mariah M Wu; Roberto Galvez; Joshua M Gulley
Journal:  Neuroscience       Date:  2016-10-01       Impact factor: 3.590

3.  Chronic binge-like alcohol consumption in adolescence causes depression-like symptoms possibly mediated by the effects of BDNF on neurogenesis.

Authors:  T L Briones; J Woods
Journal:  Neuroscience       Date:  2013-09-25       Impact factor: 3.590

4.  Amphetamine exposure alters behaviors, and neuronal and neurochemical activation in the brain of female prairie voles.

Authors:  Yan Liu; Yongliang Pan; Thomas J Curtis; Zuoxin Wang
Journal:  Neuroscience       Date:  2022-07-04       Impact factor: 3.708

5.  Overexpression of CRF in the BNST diminishes dysphoria but not anxiety-like behavior in nicotine withdrawing rats.

Authors:  Xiaoli Qi; Lidia Guzhva; Zhihui Yang; Marcelo Febo; Zhiying Shan; Kevin K W Wang; Adriaan W Bruijnzeel
Journal:  Eur Neuropsychopharmacol       Date:  2016-07-22       Impact factor: 4.600

6.  Epigenetic mechanisms underlying stress-induced depression.

Authors:  Luana Martins de Carvalho; Wei-Yang Chen; Amy W Lasek
Journal:  Int Rev Neurobiol       Date:  2020-09-26       Impact factor: 3.230

7.  The Prefrontal Dectin-1/AMPA Receptor Signaling Pathway Mediates The Robust and Prolonged Antidepressant Effect of Proteo-β-Glucan from Maitake.

Authors:  Hongkun Bao; Pengzhan Ran; Ming Zhu; Lijuan Sun; Bai Li; Yangyang Hou; Jun Nie; Liping Shan; Hongliang Li; Shangyong Zheng; Xiufeng Xu; Chunjie Xiao; Jing Du
Journal:  Sci Rep       Date:  2016-06-22       Impact factor: 4.379

8.  3'-Deoxyadenosine (Cordycepin) Produces a Rapid and Robust Antidepressant Effect via Enhancing Prefrontal AMPA Receptor Signaling Pathway.

Authors:  Bai Li; Yangyang Hou; Ming Zhu; Hongkun Bao; Jun Nie; Grace Y Zhang; Liping Shan; Yao Yao; Kai Du; Hongju Yang; Meizhang Li; Bingrong Zheng; Xiufeng Xu; Chunjie Xiao; Jing Du
Journal:  Int J Neuropsychopharmacol       Date:  2016-04-20       Impact factor: 5.176

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.